SEC Form SCHEDULE 13D filed by Mannatech Incorporated
$MTEX
Medicinal Chemicals and Botanical Products
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
MANNATECH INC (Name of Issuer) |
Common Stock, Par Value $0.0001 (Title of Class of Securities) |
563771203 (CUSIP Number) |
Robert Toth
1410 Lakeside Parkway, Suite 200
Flower Mound, TX, 75028
972-471-7400
1410 Lakeside Parkway, Suite 200
Flower Mound, TX, 75028
972-471-7400
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
01/02/2026
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP Number(s): | 563771203 |
| 1 |
Name of reporting person
TOTH ROBERT | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
SC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
99,254.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
5.1 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, Par Value $0.0001 | |
| (b) | Name of Issuer:
MANNATECH INC | |
| (c) | Address of Issuer's Principal Executive Offices:
1410 LAKESIDE PARKWAY, SUITE 200, FLOWER MOUND,
TEXAS
, 75028. | |
Item 1 Comment:
This Schedule 13D relates to shares of common stock, $0.0001 par value per share (the "Common Stock"), of Mannatech, Incorporated, a Texas corporation (the "Issuer"). The principal executive offices of the Issuer are located at 1410 Lakeside Parkway, Suite 200, Flower Mound, Texas 75028. | ||
| Item 2. | Identity and Background | |
| (a) | This Schedule 13D is being filed by Robert Toth (the "Reporting Person"). | |
| (b) | The business address of the Reporting Person is 1410 Lakeside Parkway, Suite 200, Flower Mound, Texas 75028. | |
| (c) | The Reporting Person is a Director of the Issuer and is a citizen of the United States. | |
| (d) | N/A | |
| (e) | N/A | |
| (f) | The Reporting Person is a Director of the Issuer and is a citizen of the United States. | |
| Item 3. | Source and Amount of Funds or Other Consideration | |
The shares of Common Stock reported herein were acquired in connection with an unrestricted stock grant awarded to the Reporting Person as part of the Issuer's director compensation arrangements. No cash consideration was paid by the Reporting Person. | ||
| Item 4. | Purpose of Transaction | |
The Reporting Person acquired the shares of Common Stock for investment purposes and in connection with equity compensation. The Reporting Person currently has no plans or proposals that would result in any of the actions described in Items (a) through (j) of Item 4 of Schedule 13D, though the Reporting Person may engage in discussions with management and the Board regarding the Issuer's business, operations, and governance. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | As of the most recent practicable date, the Reporting Person beneficially owns 99,254 shares of Common Stock, representing approximately 5.1% of the Issuer's outstanding Common Stock, based on 1,929,670 shares outstanding. The Reporting Person has sole voting and dispositive power with respect to these shares. | |
| (b) | As of the most recent practicable date, the Reporting Person has sole voting and dispositive power with respect to the 99,254 shares of the Issuer Common Stock. | |
| (c) | Not Applicable | |
| (d) | Not Applicable | |
| (e) | Not Applicable | |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The Reporting Person has no contracts, arrangements, understandings or relationships with respect to any securities of the Issuer other than those described herein. | ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|